20Feb 2024
Aspirin vs. LMWH for Thromboprophylaxis in ACLR: Study Findings

Aspirin vs. LMWH for Thromboprophylaxis in ACLR: Study Findings

In a study of 761 patients with low venous thromboembolism (VTE) risk undergoing anterior cruciate ligament reconstruction (ACLR), aspirin and low molecular weight heparins (LMWH) were compared for thromboprophylaxis. VTE incidence (aspirin: 1.09%, LMWH: 1.65%) and other complications showed no significant difference between groups. This suggests aspirin's comparable effectiveness to LMWH in preventing VTE post-ACLR in low-risk patients. The study highlights aspirin as a potential alternative for thromboprophylaxis in ACLR, providing valuable insights into optimizing treatment approaches for this patient population.

  • #orthopaedics

Like

Save

Share